e-Article
Utilization rate and long‐term persistence of combination pharmacotherapy with β3‐agonists and antimuscarinics for overactive bladder refractory to monotherapy in a real‐world setting.
Document Type
Article
Source
Neurourology & Urodynamics; Jun2022, Vol. 41 Issue 5, p1165-1171, 7p
Subject
Language
ISSN
07332467
Abstract
Copyright of Neurourology & Urodynamics is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)